Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Je-Hwan Lee, MD PhD, Hawk Kim, MD PhD, Young-Don Joo, MD, Won Sik Lee, Sung Hwa Bae, MD, Dae Young Zang, Jihyun Kwon, MD, Min Kyoung Kim, Junglim Lee, MD, Gyeong Won Lee, Jung-Hee Lee, MD PhD, Yunsuk Choi, MD PhD, Dae-Young Kim, MD PhD, Sung-Nam Lim, MD, Sang-Min Lee, Hun-Mo Ryoo, MD, Hyo Jung Kim, Myung Soo Hyun, Kyoo-Hyung Lee, MD PhD

Blood (2015) 126 (23): 2535.

https://doi.org/10.1182/blood.V126.23.2535.2535

Published: 2015

Journal Articles

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Blood (2015) 126 (6): 746–756.

https://doi.org/10.1182/blood-2015-03-636548

Published: 2015

Includes: Supplemental data

Journal Articles

Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 3654.

https://doi.org/10.1182/blood.V124.21.3654.3654

Published: 2014

Journal Articles

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Il hwan Kim, MD, Young Don Joo, MD PhD, Joon Ho Moon, MD PhD, Sung Nam Lim, MD, Sang Kyun Sohn, MD PhD, Gyeong Won Lee, Ho Sup Lee, Ki Young Kwon, MD PhD, Sung Hyun Kim, Kyung Tae Park, Joo Seop Chung, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Myung Soo Hyun, MD PhD, Hawk Kim, Hun-Mo Ryoo, MD, Sung Hwa Bae

Blood (2014) 124 (21): 2676.

https://doi.org/10.1182/blood.V124.21.2676.2676

Published: 2014

Journal Articles

Efficacy Of Helicobacter Pylori Eradication For The First Line Treatment Of Immune Thrombocytopenia Patients With Moderate Thrombocytopenia

Hyo Jung Kim, M.D., Won Sik Lee, M.D., Hawk Kim, M.D., Jung-Hee Lee, M.D., Sang Min Lee, M.D., Sung Hwa Bae, M.D., Myung Soo Hyun, M.D., Je-Hwan Lee, M.D.

Blood (2013) 122 (21): 2324.

https://doi.org/10.1182/blood.V122.21.2324.2324

Published: 2013

Journal Articles

Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation

Blood (2013) 122 (21): 5379.

https://doi.org/10.1182/blood.V122.21.5379.5379

Published: 2013

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia: An Interim Analysis

Je-Hwan Lee, MD, PhD, Young-Don Joo, MD, PhD, Jung-Hee Lee, Hawk Kim, MD, Sung Hwa Bae, Min Kyung Kim, MD, Dae Young Zang, Jung-Lim Lee, Gyeong Won Lee, Won Sik Lee, Jae-Hoo Park, Dae-Young Kim, Sang Min Lee, Hun Mo Ryu, Myung Soo Hyun, Hyo Jung Kim, MD, PhD, Kyoo-Hyung Lee

Blood (2012) 120 (21): 3628.

https://doi.org/10.1182/blood.V120.21.3628.3628

Published: 2012

Journal Articles

Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,

Blood (2011) 118 (21): 3424.

https://doi.org/10.1182/blood.V118.21.3424.3424

Published: 2011

Journal Articles

Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers

Blood (2011) 118 (21): 1866.

https://doi.org/10.1182/blood.V118.21.1866.1866

Published: 2011

Journal Articles

Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study

Blood (2011) 118 (21): 1517.

https://doi.org/10.1182/blood.V118.21.1517.1517

Published: 2011

Journal Articles

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Je-Hwan Lee, Young-Don Joo, Hawk Kim, Sung Hwa Bae, Min Kyoung Kim, Dae Young Zang, Jung-Lim Lee, Gyeong Won Lee, Jung-Hee Lee, Jae-Hoo Park, Dae-Young Kim, Won-Sik Lee, Hun Mo Ryoo, Myung Soo Hyun, Hyo Jung Kim, Young Joo Min, Yae-Eun Jang, Kyoo-Hyung Lee, for the Cooperative Study Group A for Hematology

Blood (2011) 118 (14): 3832–3841.

https://doi.org/10.1182/blood-2011-06-361410

Published: 2011

Journal Articles

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Blood (2010) 116 (21): 2272.

https://doi.org/10.1182/blood.V116.21.2272.2272

Published: 2010

Journal Articles

VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma

Min Kyoung Kim, Cheolwon Suh, MD, Hyun Sook Chi, Hee Soon Cho, Kyung Hee Lee, Gyeong-Won Lee, In-Suk Kim, MD, PhD, Hyeon Seok Eom, Sun-Young Kong, MD, PhD, Sung Hwa Bae, Hun-Mo Ryoo, MD, PhD, Yeung-Chul Mun, MD, PhD, Hwasoon Chung, Myung Soo Hyun

Blood (2010) 116 (21): 994.

https://doi.org/10.1182/blood.V116.21.994.994

Published: 2010

Journal Articles

High Dose Dexamethasone Vs. Conventional Dose Prednisolone for Adults with Immune Thrombocytopenia: a Prospective Multicenter Phase III Trial.

Sung Hwa Bae, Hun-Mo Ryoo, Won Sik Lee, Young Don Joo, Kyoo Hyung Lee, Je-Hwan Lee, Jung-Hee Lee, Hawk Kim, Jae Hoo Park, Min Kyoung Kim, Myung Soo Hyun, Hyo Jung Kim, Dae Young Zang

Blood (2010) 116 (21): 3687.

https://doi.org/10.1182/blood.V116.21.3687.3687

Published: 2010

Journal Articles

Addition of Hemoglobin Level Into the Prognostic Scoring System Together with White Blood Cell and Platelet Count Provides Better Prognostic Stratification for Treatment-Related Mortality and Overall Survival, but Not for Relapse Risk In Adult Patients with Acute Promyelocytic Leukemia

Jun Ho Yi, Chul Won Jung, Boram Han, Ha Yeon Lee, Jun Ho Jang, Kihyun Kim, Hyeoung Joon Kim, MD, PhD, Yeo-Kyeoung Kim, Won-Sik Lee, Young-Don Joo, Min Kyoung Kim, Myung Soo Hyun, Hawk Kim, Jae Hoo Park, Dong Hwan (Dennis) Kim

Blood (2010) 116 (21): 4371.

https://doi.org/10.1182/blood.V116.21.4371.4371

Published: 2010

Journal Articles

Prospective Randomized Comparison of Cyclophosphamide Versus Cyclophosphamide Plus Fludarabine In Addition to Anti-Thymocyte Globulin for the Conditioning Therapy In Allogeneic Hematopoietic Cell Transplantation for Bone Marrow Failure Syndrome

Hawk Kim, Jae-Hoo Park, Je-Hwan Lee, Young Don Joo, Won-Sik Lee, Sung-Hwa Bae, MD, Hun-Mo Ryoo, MD, PhD, Myung Soo Hyun, Min Kyung Kim, Dae Young Zang, Hyo Jung Kim, Kyoo Hyung Lee

Blood (2010) 116 (21): 34.

https://doi.org/10.1182/blood.V116.21.34.34

Published: 2010

Journal Articles

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 mri.

Yoo-Hong Min, Hyeoung Joon Kim, MD, PhD, Kyoo-Hyung Lee, M.D., PhD., Jae Hoon Lee, MD, PhD, Hee-Sook Park, Jin Seok Kim, Hyeok Shim, MD, Chu-Myung Seung, Chul Soo Kim, Jooseop Chung, MD, PhD, Myung Soo Hyun, Deog-Yeon Jo, MD, PhD, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, MD, PhD, Byung Soo Kim, Young-Don Joo, Chi-Young Park

Blood (2010) 116 (21): 1125.

https://doi.org/10.1182/blood.V116.21.1125.1125

Published: 2010

Journal Articles

Prognostic Factors on Survival After Hematopoietic Stem Cell Transplantation for Adult Over 40 Years In Aplastic Anemia.

Hawk Kim, Jae-Yong Kwak, Byung Soo Kim, Sung Hyun Kim, Sung-Hwa Bae, MD, Sang Kyun Sohn, Ho-Jin Shin, Jong-Ho Won, MD, PhD, Sung-Soo Yoon, Deog-Yeon Jo, MD, PhD, Young-Don Joo, Jung Hye Choi, Myung Soo Hyun, Kyoo Hyung Lee

Blood (2010) 116 (21): 1315.

https://doi.org/10.1182/blood.V116.21.1315.1315

Published: 2010

Journal Articles

Induction Therapy with “3+7” Chemotherapy Plus ATRA Followed by Consolidations with Three Courses of Idarubicin Alone and Maintenance Therapy with ATRA in Newly Diagnosed Acute Promyelocytic Leukemia (APL) Has An Excellent Leukemia-Free Survival but Minimal Toxicity in Low and Intermediate Risk Groups.

Blood (2009) 114 (22): 2072.

https://doi.org/10.1182/blood.V114.22.2072.2072

Published: 2009

Journal Articles

Efficacy of ICT with Deferasirox in Transfusional Iron Overloaded Patients with MDS or AA.

Blood (2009) 114 (22): 3810.

https://doi.org/10.1182/blood.V114.22.3810.3810

Published: 2009

NARROW

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Efficacy Of Helicobacter Pylori Eradication For The First Line Treatment Of Immune Thrombocytopenia Patients With Moderate Thrombocytopenia

Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia: An Interim Analysis

Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,

Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers

Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma

High Dose Dexamethasone Vs. Conventional Dose Prednisolone for Adults with Immune Thrombocytopenia: a Prospective Multicenter Phase III Trial.

Addition of Hemoglobin Level Into the Prognostic Scoring System Together with White Blood Cell and Platelet Count Provides Better Prognostic Stratification for Treatment-Related Mortality and Overall Survival, but Not for Relapse Risk In Adult Patients with Acute Promyelocytic Leukemia

Prospective Randomized Comparison of Cyclophosphamide Versus Cyclophosphamide Plus Fludarabine In Addition to Anti-Thymocyte Globulin for the Conditioning Therapy In Allogeneic Hematopoietic Cell Transplantation for Bone Marrow Failure Syndrome

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 mri.

Prognostic Factors on Survival After Hematopoietic Stem Cell Transplantation for Adult Over 40 Years In Aplastic Anemia.

Efficacy of ICT with Deferasirox in Transfusional Iron Overloaded Patients with MDS or AA.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only